longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CanSinoBIO

688185

102.6420.00% ( +17.11 )
Delay Closed: Sep 30, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 623.97, above the reasonable range, cheaper than 0.31% of the time in the past 5 years, and the industry ranks 44/85, the industry Median 12.05.

623.97xP/E
¥102.64Stock price
¥0.16Earnings per share
623.97xP/E
Stock price¥102.64Earnings per share¥0.16

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-13.51x
Typical range
-89.59x–32.85x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 12.05x
0156312468624

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 12.05x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688185SHCanSinoBIO
623.97x45.45%¥25.36B
688739SHCDBIO
204.64x--¥8.75B
688656SHHob Biotech
301.95x--¥8.37B
688767SHBIOTEST BIOTECH
295.75x--¥6.00B
688687SHKawin
324.50x750.00%¥3.23B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.